Yamashina Takeshi, Uedo Noriya, Dainaka Katsuyuki, Aoi Kenji, Matsuura Noriko, Ito Takashi, Fujii Mototsugu, Kanesaka Takashi, Yamamoto Sachiko, Akasaka Tomofumi, Hanaoka Noboru, Takeuchi Yoji, Higashino Koji, Ishihara Ryu, Kishi Kentaro, Fujiwara Yoshiyuki, Iishi Hiroyasu
Department of Gastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Katsuyuki Dainaka, Kenji Aoi, Noriko Matsuura, Takashi Ito, Mototsugu Fujii, Takashi Kanesaka, Sachiko Yamamoto, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ryu Ishihara, Hiroyasu Iishi), Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Department of Gastrointestinal Surgery (Kentaro Kishi, Yoshiyuki Fujiwara), Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Ann Gastroenterol. 2015 Jan-Mar;28(1):66-71.
Endoscopic resection (ER) has recently become standard treatment, even for early gastric cancer (EGC) in the remnant stomach. We aimed to compare long-term survival after ER versus radical surgery for EGC in the remnant stomach.
We retrospectively compared overall and cause-specific survival of patients who had undergone ER or radical surgery for EGC in the remnant stomach from 1998 to 2012.
During the study period, 32 patients with intramucosal (M), two with shallow submucosal (SM1) and eight with deep submucosal (SM2) cancers had undergone ER (ER group) whereas six with M and seven with SM2 cancers had undergone surgery (surgery group). All patients were followed up for a median of 60 months; during follow up, 15 patients died, including three in the ER group with SM2 cancer who died of gastric cancer. The overall 5-year survival rates of M-SM1 and SM2 cancer patients in the ER and surgery groups were 89%, 48%, 80%, and 67%, respectively (P=0.079). The disease-specific 5-year survival rates of M-SM1 and SM2 cancer patients in the ER and surgery groups were 100%, 48%, 100%, and 100%, respectively (P=0.000). Operation time and hospital stay were significantly shorter in the ER than the surgery group (P<0.001). Grade 2 perforation occurred in two patients in the ER group and Grade 3 anastomotic leakage in two patients in the surgery group.
ER provides excellent outcomes, comparable with those of radical surgery, in patients with M-SM1 gastric cancer in the remnant stomach; however, patients with SM2 cancer require radical surgery.
内镜下切除术(ER)最近已成为标准治疗方法,甚至对于残胃早期胃癌(EGC)也是如此。我们旨在比较残胃EGC患者接受ER与根治性手术后的长期生存率。
我们回顾性比较了1998年至2012年期间因残胃EGC接受ER或根治性手术的患者的总生存率和病因特异性生存率。
在研究期间,32例黏膜内癌(M)患者、2例浅黏膜下癌(SM1)患者和8例深黏膜下癌(SM2)患者接受了ER(ER组),而6例M癌患者和7例SM2癌患者接受了手术(手术组)。所有患者的中位随访时间为60个月;随访期间,15例患者死亡,包括ER组中3例SM2癌患者死于胃癌。ER组和手术组中M-SM1和SM2癌患者的总体5年生存率分别为89%、48%、80%和67%(P=0.079)。ER组和手术组中M-SM1和SM2癌患者的疾病特异性5年生存率分别为100%、48%、100%和100%(P=0.000)。ER组的手术时间和住院时间明显短于手术组(P<0.001)。ER组有2例患者发生2级穿孔,手术组有2例患者发生3级吻合口漏。
对于残胃M-SM1胃癌患者,ER的治疗效果极佳,与根治性手术相当;然而,SM2癌患者需要进行根治性手术。